Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mechanism of interaction of niflumic acid with heterologously expressed kidneyCLC-K chloride channels.
Picollo A
,
Liantonio A
,
Babini E
,
Camerino DC
,
Pusch M
.
???displayArticle.abstract???
CLC-K Cl(-) channels belong to the CLC protein family. In kidney and inner ear, they are involved in transepithelial salt transport. Mutations in ClC-Kb lead to Bartter's syndrome, and mutations in the associated subunit barttin produce Bartter's syndrome and deafness. We have previously found that 3-phenyl-CPP blocks hClC-Ka and rClC-K1 from the extracellular side in the pore entrance. Recently, we have shown that niflumic acid (NFA), a nonsteroidal anti-inflammatory fenamate, produces biphasic behavior on human CLC-K channels that suggests the presence of two functionally different binding sites: an activating site and a blocking site. Here, we investigate in more detail the interaction of NFA on CLC-K channels. Mutants that altered block by 3-phenyl-2-(p-chlorophenoxy)propionic acid (CPP) had no effect on NFA block, indicating that the inhibition binding site of NFA is different from that of 3-phenyl-CPP and flufenamic acid. Moreover, NFA does not compete with extracellular Cl(-) ions, suggesting that the binding sites of NFA are not located deep in the pore. Differently from ClC-Ka, on the rat homologue ClC-K1, NFA has only an inhibitory effect. We developed a quantitative model to describe the complex action of NFA on ClC-Ka. The model predicts that ClC-Ka possesses two NFA binding sites: when only one site is occupied, NFA increases ClC-Ka currents, whereas the occupation of both binding sites leads to channel block.
Adachi,
Two isoforms of a chloride channel predominantly expressed in thick ascending limb of Henle's loop and collecting ducts of rat kidney.
1994, Pubmed,
Xenbase
Adachi,
Two isoforms of a chloride channel predominantly expressed in thick ascending limb of Henle's loop and collecting ducts of rat kidney.
1994,
Pubmed
,
Xenbase
Birkenhäger,
Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure.
2001,
Pubmed
Brandt,
ClC-6 and ClC-7 are two novel broadly expressed members of the CLC chloride channel family.
1995,
Pubmed
,
Xenbase
Estévez,
Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion.
2001,
Pubmed
,
Xenbase
Fong,
CLC-K channels: if the drug fits, use it.
2004,
Pubmed
Gögelein,
Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas.
1990,
Pubmed
Kalgutkar,
Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors.
2000,
Pubmed
Kieferle,
Two highly homologous members of the ClC chloride channel family in both rat and human kidney.
1994,
Pubmed
Lee,
Inhibition of hKv2.1, a major human neuronal voltage-gated K+ channel, by meclofenamic acid.
1999,
Pubmed
Liantonio,
Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers.
2004,
Pubmed
,
Xenbase
Liantonio,
Activation and inhibition of kidney CLC-K chloride channels by fenamates.
2006,
Pubmed
,
Xenbase
Matsumura,
Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel.
1999,
Pubmed
McCarty,
Voltage-dependent block of the cystic fibrosis transmembrane conductance regulator Cl- channel by two closely related arylaminobenzoates.
1993,
Pubmed
,
Xenbase
Picollo,
Molecular determinants of differential pore blocking of kidney CLC-K chloride channels.
2004,
Pubmed
Pusch,
Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives.
2000,
Pubmed
,
Xenbase
Pusch,
Unique structure and function of chloride transporting CLC proteins.
2005,
Pubmed
Qu,
Anion permeation in Ca(2+)-activated Cl(-) channels.
2000,
Pubmed
,
Xenbase
Simon,
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III.
1997,
Pubmed
Uchida,
Function of chloride channels in the kidney.
2005,
Pubmed
Vandewalle,
Localization and induction by dehydration of ClC-K chloride channels in the rat kidney.
1997,
Pubmed
Vane,
Mechanism of action of nonsteroidal anti-inflammatory drugs.
1998,
Pubmed
White,
Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes.
1990,
Pubmed
,
Xenbase
